[1]
“NEUROLOGICAL COMPLICATIONS IN COVID PATIENTS”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 2, pp. 279–289, Mar. 2022, doi: 10.25004/IJPSDR.2022.140219.